Presentation
7 March 2019 Targeting drug-resistant glioblastoma stem cells using photodynamic therapy (Conference Presentation)
Bryan Q. Spring, Kohei Watanabe, Megumi Ichikawa, Srivalleesha Mallidi, Tatsuyuki Matsudaira, Dmitriy Timerman, Hiroaki Wakimoto, Tayyaba Hasan
Author Affiliations +
Abstract
Standard chemoradiation often enriches drug-resistant tumor cell populations that can lead to recurrent and treatment-refractory disease. Preclinical models of glioblastoma brain tumors, for instance, suggest that the cancer stem cell subpopulation becomes enriched and re-populates the tumor milieu following conventional therapies. Here, we show evidence that photodynamic therapy (PDT) is effective against several patient-derived glioblastoma stem cell cultures. Moreover, sub-lethal PDT results in re-sensitization of cancer stem cell phenotypes with induced drug-resistance to chemotherapy.
Conference Presentation
© (2019) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Bryan Q. Spring, Kohei Watanabe, Megumi Ichikawa, Srivalleesha Mallidi, Tatsuyuki Matsudaira, Dmitriy Timerman, Hiroaki Wakimoto, and Tayyaba Hasan "Targeting drug-resistant glioblastoma stem cells using photodynamic therapy (Conference Presentation)", Proc. SPIE 10860, Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XXVIII, 1086004 (7 March 2019); https://doi.org/10.1117/12.2510962
Advertisement
Advertisement
KEYWORDS
Photodynamic therapy

Stem cells

Tumors

Cancer

Brain

Therapeutics

Tumor growth modeling

Back to Top